"10.1371_journal.pone.0072967","plos one","2013-08-23T00:00:00Z","Anastasia Wyce; Gopinath Ganji; Kimberly N Smitheman; Chun-wa Chung; Susan Korenchuk; Yuchen Bai; Olena Barbash; BaoChau Le; Peter D Craggs; Michael T McCabe; Karen M Kennedy-Wilson; Lydia V Sanchez; Romain L Gosmini; Nigel Parr; Charles F McHugh; Dashyant Dhanak; Rab K Prinjha; Kurt R Auger; Peter J Tummino","Cancer Epigenetics Discovery Performance Unit, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America; Molecular Medicine Unit, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America; Platform Technology and Science, GlaxoSmithKline, Stevenage, United Kingdom; Platform Technology and Science, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America; Lipid Metabolism Discovery Performance Unit, GlaxoSmithKline, Les Ulis, France; Epinova Discovery Performance Unit, GlaxoSmithKline, Stevenage, United Kingdom","Conceived and designed the experiments: AW PC KS CC SK RP DD KA PT. Performed the experiments: AW SK KS BL CC PC RG YB MTM. Analyzed the data: AW GG KS CC SK BL CM YB MTM. Contributed reagents/materials/analysis tools: KKW LS RG NP. Wrote the manuscript: AW OB KA PT.","The authors have read the journal's competing interest policy and have the following conflicts to disclose: all authors are current or former employees of GlaxoSmithKline. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Anastasia Wyce","AW",19,TRUE,9,9,9,4,TRUE,TRUE,FALSE,0,NA,FALSE
